Vaccine

© GettyImages/solarseven

Cobra to supply plasmids to UK COVID-19 vaccine developer

By Jane Byrne

Contract development and manufacturing organization (CDMO), Cobra Biologics, has been selected to manufacture plasmids for a Phase I clinical trial of a COVID-19 vaccine being developed by UK company, Scancell.

© GettyImages/AndreyPopov

Crowdfunding COVID-19 vaccine development

By Jane Byrne

Axon Neuroscience is launching the world's first crowdfunding exercise for the development of a COVID-19 vaccine, following what it says are strong pre-clinical results for its candidate.

© GettyImages/vchal

Spotlight on Moderna funding declarations in patent filings

By Jane Byrne

Two US government agencies are investigating whether Moderna Therapeutics, the biotech company behind one of the leading Covid-19 vaccine candidates, was upfront about government funding in its filed or awarded patents, as required by federal law.

(Image: Getty/Sinhyu)

‘Safe’ virus discovered for vaccine production

By Ben Hargreaves

Researchers have discovered a virus that is unable to replicate in humans and is ‘tolerant to genetic manipulation’ that could be used to protect humans from dangerous infectious diseases.

(Image: Getty/Zerbor)

GSK’s shingles vaccine approved in China

By Maggie Lynch

GSK is investing in ‘significant’ capacity expansion to support production of its shingles vaccine, which has been approved in China after clinical trials demonstrated 90% efficacy.

Merck & Co.'s top-selling vaccine is its HPV vaccination Gardasil/Gardasil 9. Image: By Jan Christian @ www.ambrotosphotography.com CC BY-SA 2.0 (http://creativecommons.org/licenses/by-sa/2.0), via Wikimedia Commons

CEO scouts top E&W Coast scientific talent to secure Merck & Co.'s future

‘Don’t underestimate Merck's vaccine business,’ says CEO

By Dan Stanton

CEO Ken Frazier has told investors investments and partnerships, such as collaboration with messenger RNA firm Moderna Therapeutics, have bolstered Merck & Co.’s vaccine division.